Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 1 |
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
J Math Biol. 2023 Dec 15;88(1):10. doi: 10.1007/s00285-023-02027-y.
J Math Biol. 2023.
PMID: 38099947
Free PMC article.
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
Anderson HG, Takacs GP, Harris DC, Kuang Y, Harrison JK, Stepien TL.
Anderson HG, et al.
bioRxiv [Preprint]. 2023 Sep 7:2023.05.15.540846. doi: 10.1101/2023.05.15.540846.
bioRxiv. 2023.
PMID: 37292799
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases.
Von Roemeling CA, Doonan BP, Klippel K, Schultz D, Hoang-Minh L, Trivedi V, Li C, Russell RA, Kanumuri RS, Sharma A, Tun HW, Mitchell DA.
Von Roemeling CA, et al.
Clin Cancer Res. 2023 May 1;29(9):1751-1762. doi: 10.1158/1078-0432.CCR-22-1682.
Clin Cancer Res. 2023.
PMID: 36749885
Free PMC article.
Item in Clipboard
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner.
Takacs GP, Kreiger CJ, Luo D, Tian G, Garcia JS, Deleyrolle LP, Mitchell DA, Harrison JK.
Takacs GP, et al.
Front Immunol. 2023 Jan 4;13:993444. doi: 10.3389/fimmu.2022.993444. eCollection 2022.
Front Immunol. 2023.
PMID: 36685592
Free PMC article.
Item in Clipboard
Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.
Takacs GP, Flores-Toro JA, Harrison JK.
Takacs GP, et al.
Pharmacol Ther. 2021 Jun;222:107790. doi: 10.1016/j.pharmthera.2020.107790. Epub 2020 Dec 11.
Pharmacol Ther. 2021.
PMID: 33316289
Free PMC article.
Review.
Item in Clipboard
Adult immuno-oncology: using past failures to inform the future.
Rahman M, Sawyer WG, Lindhorst S, Deleyrolle LP, Harrison JK, Karachi A, Dastmalchi F, Flores-Toro J, Mitchell DA, Lim M, Gilbert MR, Reardon DA.
Rahman M, et al.
Neuro Oncol. 2020 Sep 29;22(9):1249-1261. doi: 10.1093/neuonc/noaa116.
Neuro Oncol. 2020.
PMID: 32391559
Free PMC article.
Item in Clipboard
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA, Luo D, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M, Jain RK, Mitchell DA, Harrison JK.
Flores-Toro JA, et al.
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1129-1138. doi: 10.1073/pnas.1910856117. Epub 2019 Dec 26.
Proc Natl Acad Sci U S A. 2020.
PMID: 31879345
Free PMC article.
Item in Clipboard
Cite
Cite